New Therapy Targeting ApoC3 Reduces Triglyceride Levels and Lowers Cardiovascular Risk in Individuals with Mixed Hyperlipidemia
Baylor College of Medicine researchers have reported promising findings from a study on a novel therapy that effectively lowers triglyceride levels in individuals diagnosed with …